Institutional investors purchased a net $12.0 million shares of AZN during the quarter ended December 2014 and now own 7.54% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 6.4 Million shares of AstraZeneca
MERRILL LYNCH, PIERCE, FENNER & ... Bought 3.5 Million shares of AstraZeneca
MANAGED ACCOUNT ADVISORS LLC Bought 1.8 Million shares of AstraZeneca